Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 3, 2005, Pages 137-146

  Joyner, David E ^a   Wade, Mark L ^a   Szabo, Aniko ^a   Bastar, Jeffrey ^a   Coffin, Cheryl M ^a   Albritton, Karen H ^a,b   Bernard, Philip S ^a   Randall, R Lor ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cDNA microarray; Gene expression profiles; Mesenchymal tumors

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ANALYSIS OF VARIANCE; ARTICLE; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DNA FINGERPRINTING; DNA MICROARRAY; EWING SARCOMA; FIBROBLAST CULTURE; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GIANT CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; MESENCHYMOMA; NERVE SHEATH TUMOR; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; SARCOMA; SPINDLE CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; CARCINOMA; CARCINOMA, GIANT CELL; CELL LINE; DNA FINGERPRINTING; DNA, NEOPLASM; FEASIBILITY STUDIES; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINEAR MODELS; MESENCHYMOMA; NEOPLASMS, CONNECTIVE TISSUE; NERVE SHEATH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, EWING'S; SKIN;

EID: 12944324219     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0640-1     Document Type: Article

References (44)

1. Aalfs CM, Salieb-Beugelaar B, Wanders RJA, Mannens MMAM, Wijburg FA (2000) A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis. Human Mutation 16:18-22
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
3. Arbiser ZK, Folpe AL, Weiss SW (2001) Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 116:473-476
4. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
5. Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong S-S (2000) Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78:627-637
6. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St. Croix B (2001) Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61:6649-6655
7. Chiellini C, Costa M, Novelli SE, Amri E-Z, Benzi L, Bertacca A, Cohen P, Del Prato S, Friedman JM, Maffei M (2003) Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol 195:309-321
8. Chung CH, Bernard PS, Perou CM (2002) Molecular portraits and the family tree of cancer. Nature Genetics (Suppl) 32:533-540
9. Fletcher CDM, Unni KK, Mertens F (eds) (2002) World health organization classification of tumors. Pathology & genetics of tumours of soft tissue and bone. IARC, Lyon, pp 427
10. Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K definciency. Science 273:1236-1238
11. Gonzalez-Garcia I, Sole RV, Costa J (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA 99:13085-13089
12. Grier HE (1999) Soft tissue sarcoma: apples, oranges, and passion fruit. J Clin Oncol 17:3695-3696
13. Habelhah H, Okada F, Kobayashi M, Nakai K, Choi S, Hamada J, Moriuchi T, Kaya M, Yoshida K, Fujinaga K, Hosokawa M (1999) Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 18:1771-1776
14. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790
15. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K (1995) Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10:1461-1463
16. Kenjiro A, Woodman A, Urquidi V, Mangham DC, Tarin D, Goodsin S (2000) Telomerase activity in soft-tissue and bone sarcomas. Clin Cancer Res 6:4776-4781
17. Kerr MK, Martin M, Churchill GA (2000) Analysis of variance for gene expression microarray data. J Comput Biol 7:819-837
18. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673-679
19. Letson GD, Muro-Cacho CA (2001) Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Control 8:239-251
20. Lopez M, Vici P, Di Lauro L, Carpano S (2002) Increasing single epirubicin doses in advanced soft tissue sarcomas. J Clin Oncol 20:1329-1334
21. Mackall CL, Meltzer PS, Helman LJ (2002) Focus on sarcomas. Cancer Cell 2:175-178
22. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi O-P (2002) Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62:1256-1260
23. Nagayama S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N, Kusuzaki K, Nakayama T, Tsuboyama T, Nakamura T, Imamura M, Nakamura Y, Toguchida J (2002) Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 62:5859-5866
24. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Bolstein D, van de Rijn M (2002) Molecular characterization of soft tissue tumours: a gene expression study. Lancet 359:1301-1307
25. Owens JM, Matsuo K, Nicholson GC, Wagner EF, Chambers TJ (1999) Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol 179:170-178
26. Ramos-Nino ME, Scapoli L, Martinelli M, Land S, Mossman BT (2003) Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res 63:3539-3545
27. Randall RL, Wade ML, Albritton KH, Joyner DE (2003a) Retrieval yield of total and messenger RNA in mesenchymal tissue ex vivo. Clin Ortho Ret Res 415:59-63
28. Randall RL, Wade ML, Coffin CM, Albritton KH, Joyner DE (2003b) cDNA microarray analysis to distinguish tumor type ex vivo. Clin Ortho Rel Res 415:8110-8119
29. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103:211-225
30. Searle SR, Casella G, McCullogh CE (1992) Variance components. Wiley series in probability and statistics. Wiley, New York
31. Sgroi, DC, Teng S, Robinson G, LeVangie R, Hudson, Jr JR, Elkahloun AG (1999) In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 59:5656-5661
32. 2-terminal amino kinases, protracted expression of the activator protein-1 protooncogene, fra-1, and s-phase alterations are mediated via oxidative stress. Cancer Res 61:1791-1795
33. Sorci-Thomas M, Babiak J, Rudel LL (1990) Lecithin-cholesterol acyltransferase (LCAT) catalyzes transacylation of intact cholesteryl esters. J Biol Chem 265:2665-2670
34. Spremulli EN, Dexter DL (1983) Human tumor cell heterogeneity and metastasis. J Clin Oncol 1:496-509
35. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
36. Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc, Series B, 64:479-498
37. Szabo A, Boucher K, Carroll WL, Klebanov LB, Tsodikov AD, Yakovlev AY (2002) Variable selection and pattern recognition wilh gene expression data generated by the microarray technology. Math Biosciences 176:71-98
38. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
39. Uria JA, Balbin M, Lopez JM, Alvarez J, Vizoso F, Takigawa M, Lopez-Otin C (1998) Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 153:91-101
40. Weber GF, Bronson RT, Ilagan J, Cantor H, Schmits R, Mak TW (2002) Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res 62:2281-2286
41. Wernisch L, Kendall SL, Soneji S, Wietzorrek A, Parish T, Hinds J, Butcher PD, Stoker NG (2003) Analysis of whole-genome microarray replicates using mixed models. Bioinformatics 19:53-61
42. Westermarck J, Kahari V-M (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792
43. Wheelock MJ, Johnson KR (2003) Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 19:207-235
44. Yang YH, Dudoit S, Luu P, Speed TP (2000) Normalization of cDNA microarray data. Technical Report 589, Department of Statistics, University of California, Berkeley